Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12605000639628Phase 4Completed
Phase 4, randomised, double-blind trial in cardiac morbidity and cardiovascular complications comparing Atenolol with Placebo (2 arms). Primary endpoints: Patient mortality and Cardiovascular morbidity. Started Dec 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12605000639628.